Excerpt from:
Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Category Archives: Global News Feed
Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference
Read the original here:
Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference
Myriad Genetics to Present at 42nd Annual J.P. Morgan Healthcare Conference
Sana Biotechnology to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
Foghorn Therapeutics Announces CFO Departure
Read the original:
Foghorn Therapeutics Announces CFO Departure
Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference
The rest is here:
Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Monthly information related to total number of voting rights and shares composing the share capital – December 31, 2023
Madrigal Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
Here is the original post:
Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
Disc Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference
BridgeBio Pharma to Participate in the J.P. Morgan Healthcare Conference
See the original post here:
BridgeBio Pharma to Participate in the J.P. Morgan Healthcare Conference
Burning Rock Announces Receipt of Notification from NASDAQ
See original here:
Burning Rock Announces Receipt of Notification from NASDAQ
Hepion Pharmaceuticals to Present at NASH-TAG 2024
Read the original here:
Hepion Pharmaceuticals to Present at NASH-TAG 2024
ABVC BioPharma Enters Definitive Agreement with Licensing Income Worth $467M and Royalties Up to $200M
Bright Green Corporation announces exclusive partnership with Asia Capital Pioneers Group to present new EB-5 offering
CoRegen Appoints Edward J. Benz, M.D., to its Board of Directors
Go here to read the rest:
CoRegen Appoints Edward J. Benz, M.D., to its Board of Directors
Kane Biotech Strengthens Board with Biotech Executive
Excerpt from:
Kane Biotech Strengthens Board with Biotech Executive